| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 10/12/2006 | WO2006107708A1 Treatment of disease caused by excess free hemoglobin |
| 10/12/2006 | WO2006107258A1 Novel 5-substituted 7-amino-[1,3]thiazolo[4,5-d]pyrimidine derivatives |
| 10/12/2006 | WO2006107257A1 Novel 5,7-disubstituted [1,3]thiazolo[4,5-d]pyrimidin-2(3h)-one derivatives |
| 10/12/2006 | WO2006107027A1 Agent for prevention or treatment of nocturnal behavioral disorder associated with dementia |
| 10/12/2006 | WO2006107019A1 Preventive or remedy for depression or anxiety neurosis |
| 10/12/2006 | WO2006106926A1 Lignane compound-containing oil-in-water emulsion and composition comprising the same |
| 10/12/2006 | WO2006106915A1 PROTECTIVE AGENT FOR RETINAL NEURONAL CELL CONTAINING PROSTAGLANDIN F2α DERIVATIVE AS ACTIVE INGREDIENT |
| 10/12/2006 | WO2006106727A1 Benzyloxypropylamine derivative |
| 10/12/2006 | WO2006106704A1 Composition for improvement of alcohol metabolism in blood |
| 10/12/2006 | WO2006106599A1 Pharmaceutical for preventing and/or treating disease caused by abnormal enhancement of extracellular domain shedding |
| 10/12/2006 | WO2006106425A1 Bicyclic [3.1.0] heteroaryl amides as type i glycine transport inhibitors |
| 10/12/2006 | WO2006106416A1 PYRIDIL-LACTAMS AND THEIR USE 5 -HTl RECEPTORS LIGAN |
| 10/12/2006 | WO2006106308A1 Therapeutic use of nefopam and analogues thereof |
| 10/12/2006 | WO2006106241A1 Piperazine derivatives and use thereof as serotonin reuptake inhibitors or as neurokinin antagonists |
| 10/12/2006 | WO2006106135A1 Crystal form of asenapine maleate |
| 10/12/2006 | WO2006106090A1 Novel substituted diazabicyclo derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 10/12/2006 | WO2006106054A1 Pyridine-3-carboxamide derivatives as cb1 inverse agonists |
| 10/12/2006 | WO2006105979A1 Sulfonylpyrroles as histone deacetylase inhibitors |
| 10/12/2006 | WO2006105971A1 Substituted 5,6,7,8-tetrahydro-imidazo[1,2-a]pyridin-2-ylamine compounds and their use for producing drugs |
| 10/12/2006 | WO2006105811A1 Compounds useful as modulators of the proteasome activity |
| 10/12/2006 | WO2006105806A1 Delaying the ageing process and disorders caused by ageing |
| 10/12/2006 | WO2006105795A1 Novel indolinone derivatives |
| 10/12/2006 | WO2006069739A3 Polypeptide species useful for the treatment of neurological disorders |
| 10/12/2006 | WO2006064351A3 N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenalin re-uptake inhibitors |
| 10/12/2006 | WO2006047516A3 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
| 10/12/2006 | WO2006039792A8 Method of treating autoimmune diseases |
| 10/12/2006 | WO2006010591A3 Quinazoline derivatives |
| 10/12/2006 | WO2005123703A3 Alkynyl derivatives as modulators of metabotropic glutamate receptors |
| 10/12/2006 | WO2005097200A3 Tetanus toxin fusion protein for visualization of active synapses |
| 10/12/2006 | US20060229363 Substituted Heteroaryl- and Phenylsulfamoyl Compounds |
| 10/12/2006 | US20060229339 Novel use of substituted aminomethyl chromans |
| 10/12/2006 | US20060229338 2,3'-bipyridines derivatives as selective cox-2 inhibitors |
| 10/12/2006 | US20060229333 Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
| 10/12/2006 | US20060229324 Quinazolin-4-one derivatives |
| 10/12/2006 | US20060229321 Rosuvastatin in pre demented states |
| 10/12/2006 | US20060229320 Enantiomers of 1-[(4-chlorophenyl) phenylmethyl]-4-[(4-methylphenyl) sulfonyl] piperazine |
| 10/12/2006 | US20060229319 For treatment of allergies; antihistamines |
| 10/12/2006 | US20060229318 trans-1-{2-[(3,5-dibromobenzyl)oxy]-2,3-dihydro-1H-inden-1-yl}piperazine; serotonin reuptake inhibitor and/or neurokinin NK1 antagonist; antidepressant, anxiolytic agent; cognition activator; psychological disorders; obesity, gastrointestinal disorders |
| 10/12/2006 | US20060229315 3-Substituted Quinoline-4-Carboxamide Derivatives as NK-3 and NK-2 Receptor Antagonists |
| 10/12/2006 | US20060229311 Isatine derivatives with neurotrophic activity |
| 10/12/2006 | US20060229308 Substituted pyrirmidin-4-ylamine analogues as vanilloid receptor ligands |
| 10/12/2006 | US20060229301 To treat inflammatory diseases, immune diseases like autoimmune diseases or allergic diseases, or HIV infection; chemokine receptor antagonists; safe and low-toxic; 1-butyl-3-isobutyl-1,3,8-triazaspiro[4.5]decane-2,4-dione |
| 10/12/2006 | US20060229299 5ht2c Receptor antagonists in the treatment of schizophrenia |
| 10/12/2006 | US20060229298 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues |
| 10/12/2006 | US20060229297 (THIO) Carbamoyl-cyclohexane derivatives as D3/D2 receptor antagonists |
| 10/12/2006 | US20060228752 Genetic polymorphisms in the preprotachykinin gene |
| 10/12/2006 | US20060228407 Enhanced delivery via serpin enzyme complex receptor |
| 10/12/2006 | US20060228371 Immunological control of beta-amyloid levels in vivo |
| 10/12/2006 | US20060228341 Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof |
| 10/12/2006 | DE20321314U1 Retarded release pharmaceutical composition, obtained without use of organic solvents or water by densifying mixture of active agent and retarding polymer in heated rollers |
| 10/12/2006 | DE19940944B4 Retardierte, orale, pharmazeutische Darreichungsformen Prolonged-release oral pharmaceutical dosage forms |
| 10/12/2006 | DE102005015646A1 Treatment of sheep's wool for retaining lanolin for filling fiber with medicinal properties involves washing in warm salt solution |
| 10/12/2006 | CA2604396A1 Therapeutic use of nefopam and analogues thereof |
| 10/12/2006 | CA2604133A1 Compounds useful as modulators of the proteasome activity |
| 10/12/2006 | CA2604016A1 Novel 5,7-disubstituted [1,3]thiazolo[4,5-d]pyrimidin-2(3h)-one derivatives |
| 10/12/2006 | CA2603939A1 Bicyclic [3.1.0] heteroaryl amides as type i glycine transport inhibitors |
| 10/12/2006 | CA2603509A1 Crystal form of asenapine maleate |
| 10/12/2006 | CA2603398A1 Sulfonylpyrroles as histone deacetylase inhibitors |
| 10/12/2006 | CA2603347A1 Oil-in-water emulsions of lignans that exhibit improved absorption rate |
| 10/12/2006 | CA2603129A1 Crystalline forms of pregabalin |
| 10/12/2006 | CA2603030A1 Benzyloxypropylamine derivative |
| 10/12/2006 | CA2602787A1 Pyridine-3-carboxamide derivatives as cb1 inverse agonists |
| 10/12/2006 | CA2602623A1 Substituted 5,6,7,8-tetrahydro-imidazo[1,2-a]pyridin-2-ylamine compounds and their use for producing drugs |
| 10/12/2006 | CA2601988A1 Prophylactic or therapeutic agent for noctural conduct disorder associated with dementia |
| 10/12/2006 | CA2599922A1 Use of n-desmethylclozapine and related compounds as dopamine stabilizing agents |
| 10/11/2006 | EP1710307A2 RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA) |
| 10/11/2006 | EP1710245A1 Crystal form of asenapine maleate |
| 10/11/2006 | EP1710240A1 Piperazine derivatives and their use as serotonin reuptake inhibitors or as neurokinin antagonists |
| 10/11/2006 | EP1709974A2 Method of treating cardiovascular disease using rapamycin |
| 10/11/2006 | EP1709968A1 P2x receptor inhibitor |
| 10/11/2006 | EP1709967A1 Agents for treating migraine |
| 10/11/2006 | EP1709966A1 Preventive and/or therapeutic agent for higher brain dysfunction |
| 10/11/2006 | EP1709965A2 Methods of treating cytokine mediate diseases |
| 10/11/2006 | EP1709957A2 Sustained-release analgesic compounds |
| 10/11/2006 | EP1709161A2 Human therapeutic cells secreting nerve growth factor |
| 10/11/2006 | EP1709052A1 Derivatives of 1,4-diazabicyclo 3.2.1octanecarboxamide, preparation method thereof and use of same in therapeutics |
| 10/11/2006 | EP1709045A1 Naphthyridine derivatives and their use as modulators of muscarinic receptors |
| 10/11/2006 | EP1709042A1 Spirocyclic quinuclidinic ether derivatives |
| 10/11/2006 | EP1709018A1 Acylaminothiazole derivatives and use thereof as beta-amyloid inhibitors |
| 10/11/2006 | EP1709009A1 6-amino-5-cyano-pyrimidine-4-ones used for improving perception, power of concentration, learning efficiency, and/or memory power |
| 10/11/2006 | EP1708994A1 Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics |
| 10/11/2006 | EP1708790A1 Use of d4 and 5-ht2a antagonists, inverse agonists or partial agonists |
| 10/11/2006 | EP1708731A2 Neuroprotective dietary supplement |
| 10/11/2006 | EP1708718A1 Triazole derivatives which inhibit vasopressin antagonistic activity |
| 10/11/2006 | EP1708713A1 1-benzyl-5-piperazin-1-yl-3,4 dihydro-1h-quinazolin-2-one derivatives and the respective 1h-benzo(1,2,6)thiadiazine-2,2-dioxide and 1,4-dihydro-benzo(d)(1,3)oxazin-2-one derivatives as modulators of the 5-hydroxytryptamine receptor (5-ht) for the treatment of diseases of the central nervous system |
| 10/11/2006 | EP1708707A1 Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an n-methyl-d-aspartate (nmda) receptors antagonist |
| 10/11/2006 | EP1708706A1 Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and a dopamine agonist |
| 10/11/2006 | EP1708700A1 Metal salts of parecoxib as prodrugs of the cox-2 inhibitor valdecoxib for the treatment of inflammation, pain and/or fever |
| 10/11/2006 | EP1250600B1 Diagnosis of tauopathies determining tau/phospho-tau ratio |
| 10/11/2006 | EP1216232B1 Heterocyclic compounds and methods for modulating cxcr3 function |
| 10/11/2006 | EP1147134B1 Novel potassium channels and genes encoding these potassium channels |
| 10/11/2006 | EP0972041B1 Novel human delta3 compositions and therapeutic and diagnostic uses therefor |
| 10/11/2006 | CN1846456A Transmitter of wireless microphone, receiver for wireless microphone, mobile information communication apparatus, and communication system for wireless microphone |
| 10/11/2006 | CN1845744A The combination of a serotonin reuptake inhibitor and amoxapine |
| 10/11/2006 | CN1845743A Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep |
| 10/11/2006 | CN1845742A Method of stabilizing diarylvinylene compound |
| 10/11/2006 | CN1845735A Novel medical use of selective cb1-receptor antagonists |
| 10/11/2006 | CN1845730A The combination of a serotonin reuptake inhibitor and loxapine |
| 10/11/2006 | CN1845727A Curing and prophylactic agent applied during the use of alcohol and psychoactive substances |
| 10/11/2006 | CN1844127A Caffeoyl guinic acid-1-phosphate and its preparation and use |